ATE515269T1 - Gag-bindende proteine - Google Patents

Gag-bindende proteine

Info

Publication number: ATE515269T1
Authority: AT; Austria
Prior art keywords: gag; binding proteins; proteins; binding
Prior art date: 2003-12-04

Application number

AT04801190T

Other languages

English (en)

Inventor

Andreas J Kungl

Original Assignee

Protaffin Biotechnologie Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-04

Filing date

2004-12-02

Publication date

2011-07-15

2004-12-02 Application filed by Protaffin Biotechnologie Ag filed Critical Protaffin Biotechnologie Ag

2011-07-15 Application granted granted Critical

2011-07-15 Publication of ATE515269T1 publication Critical patent/ATE515269T1/de

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
- C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5421—IL-8
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Toxicology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pulmonology (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Dermatology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

AT04801190T 2003-12-04 2004-12-02 Gag-bindende proteine ATE515269T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
AT0195203A AT412785B (de)	2003-12-04	2003-12-04	Gag-bindungsproteine
PCT/EP2004/013670 WO2005054285A1 (en)	2003-12-04	2004-12-02	Gag binding proteins

Publications (1)

Publication Number	Publication Date
ATE515269T1 true ATE515269T1 (de)	2011-07-15

Family

ID=33494536

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
AT0195203A AT412785B (de)	2003-12-04	2003-12-04	Gag-bindungsproteine
AT04801190T ATE515269T1 (de)	2003-12-04	2004-12-02	Gag-bindende proteine
AT06117339T ATE439376T1 (de)	2003-12-04	2004-12-02	Gag-bindende proteine

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AT0195203A AT412785B (de)	2003-12-04	2003-12-04	Gag-bindungsproteine

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AT06117339T ATE439376T1 (de)	2003-12-04	2004-12-02	Gag-bindende proteine

Country Status (20)

Country	Link
US (4)	US7585937B2 (de)
EP (5)	EP2270038A3 (de)
JP (3)	JP4980721B2 (de)
KR (2)	KR101278459B1 (de)
CN (1)	CN1890264B (de)
AT (3)	AT412785B (de)
AU (1)	AU2004295104B2 (de)
BR (1)	BRPI0416544A (de)
CA (1)	CA2546789A1 (de)
CY (2)	CY1109480T1 (de)
DE (1)	DE602004022595D1 (de)
DK (2)	DK1689775T3 (de)
ES (2)	ES2330362T3 (de)
IL (1)	IL175565A0 (de)
NZ (1)	NZ547612A (de)
PL (2)	PL1752470T3 (de)
PT (2)	PT1752470E (de)
SG (1)	SG149000A1 (de)
SI (2)	SI1752470T1 (de)
WO (1)	WO2005054285A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AT412785B (de) *	2003-12-04	2005-07-25	Kungl Andreas J Dr	Gag-bindungsproteine
WO2007030930A1 (en)	2005-09-13	2007-03-22	National Research Council Of Canada	Methods and compositions for modulating tumor cell activity
CN100366637C (zh) *	2005-11-17	2008-02-06	中国人民解放军第四军医大学	人白细胞介素8拮抗蛋白及其制备方法
US9422356B2 (en) *	2006-01-31	2016-08-23	Republic Of Korea (Republic Of National Fisheries Research And Development Institute)	Artificial signal peptide for expressing an insoluble protein as a soluble active form
US8168181B2 (en)	2006-02-13	2012-05-01	Alethia Biotherapeutics, Inc.	Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
CA2638823A1 (en)	2006-02-13	2007-08-23	Alethia Biotherapeutics Inc.	Polynucleotides and polypeptide sequences involved in the process of bone remodeling
EP1894571A1 (de) *	2006-08-29	2008-03-05	Protaffin Biotechnologie AG	Verwendung von modifizierten IL-8 Proteinen zur Behandlung von Reperfusionsschäden und Transplantatabstossung
WO2008140500A2 (en) *	2006-12-08	2008-11-20	The University Of Miami	Hyaluronidase inhibitors as anti-cancer agents
AT504685B1 (de) *	2006-12-20	2009-01-15	Protaffin Biotechnologie Ag	Fusionsproteine
BRPI0811293A2 (pt) *	2007-05-07	2017-05-16	Peptimmune Inc	métodos para a expansão direta de epítopos para uso com ligantes de anticorpo.
EP2042516A1 (de) *	2007-09-27	2009-04-01	Protaffin Biotechnologie AG	Glycosaminoglycan-antagonisierende MCP-1-Mutanten und Verfahren zu seiner Verwendung
EP2185719B1 (de)	2007-08-02	2013-11-13	NovImmune SA	Rantes-antikörper und verfahren zu ihrer verwendung
EP2053060A1 (de)	2007-10-24	2009-04-29	Protaffin Biotechnologie AG	SDF-1-basierte Glycosamingolycan-Antagonisten und Verfahren zu ihrer Verwendung
WO2009099631A1 (en) *	2008-02-08	2009-08-13	Miles Lindsey A	Novel plasminogen receptor, polypeptides & antibodies thereof
WO2010086426A1 (en)	2009-01-30	2010-08-05	Protaffin Biotechnologie Ag	Glycosaminoglycan-antagonising mcp-i mutants and methods of using same
EA201200470A1 (ru)	2009-09-11	2012-08-30	Протаффин Биотехнологие Аг	Композиция для лечения опосредуемого cxcl8 воспаления легкого
CA2928846A1 (en)	2009-11-24	2011-06-03	Alethia Biotherapeutics Inc.	Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume
GB201012603D0 (en) *	2010-07-27	2010-09-08	Ucb Pharma Sa	Protein purification
EP2686344A1 (de)	2011-03-16	2014-01-22	Protaffin Biotechnologie AG	Fgfr1-basierte antagonisten mit verbesserter glycosaminoglycanaffinität und verwendungsverfahren dafür
WO2013007704A2 (en)	2011-07-08	2013-01-17	Protaffin Biotechnologie Ag	Novel sdf-1-based glycosaminoglycan antagonist and methods of using same
CN104159611A (zh)	2012-02-22	2014-11-19	阿莱斯亚生物疗法股份有限公司	共使用簇集蛋白抑制剂和egfr抑制剂以治疗癌症
CA2928851A1 (en)	2012-07-19	2014-01-23	Alethia Biotherapeutics Inc.	Anti-siglec-15 antibodies
WO2014079957A1 (de) *	2012-11-23	2014-05-30	Bayer Cropscience Ag	Selektive inhibition der ethylensignaltransduktion
KR101457371B1 (ko) *	2013-01-10	2014-11-04	강원대학교산학협력단	작은안구증-연관 전사인자 유래의 펩타이드 및 이를 포함하는 조성물
US10047133B2 (en)	2014-01-22	2018-08-14	Antagonis Biotherapeutics Gmbh	Glycosaminoglycan-antagonising fusion proteins and methods of using same
WO2021038033A1 (en)	2019-08-29	2021-03-04	Antagonis Biotherapeutics Gmbh	T-cell mobilizing cxcl10 mutant with increased glycosaminoglycan binding affinity
CN110791523B (zh) *	2019-12-13	2022-05-10	南京农业大学	一种棉花抗旱相关基因GhRCHY1及其应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4960691A (en) *	1986-09-29	1990-10-02	Abbott Laboratories	Chromatographic test strip for determining ligands or receptors
US5234911A (en) *	1990-07-09	1993-08-10	Gist-Brocades, N.V.	Substance with interleukin-8 inhibiting activity and process for its preparation
WO1992007935A1 (en) *	1990-11-01	1992-05-14	The Scripps Research Institute	Glycosaminoglycan-targeted fusion proteins, their design, construction and compositions
DK0607777T3 (da) *	1993-01-08	1999-08-16	Hoechst Ag	Anvendelse af leflunomid til inhibering af interleukin 8
JP2694321B2 (ja) *	1993-03-10	1997-12-24	大塚製薬株式会社	インターロイキン−１阻害剤
US5527546A (en) *	1994-08-10	1996-06-18	Bayer Corporation	Human interleukin 6 inhibitor
US5866402A (en)	1995-05-05	1999-02-02	Chiron Corporation	Chimeric MCP and DAF proteins with cell surface localizing domain
JPH1045602A (ja) *	1996-07-31	1998-02-17	Motoyasu Murakami	ヘリコバクター・ピロリ接着阻害剤またはインターロイキン−８産生阻害剤
US6852696B2 (en) *	1999-03-26	2005-02-08	The University Of Texas System	Inhibitors of glycosaminoglycans
EP1581615B1 (de)	2000-09-05	2010-04-28	Biosight Ltd	Peptid-konjugierte antikrebs-prodrugs
UA77950C2 (en) *	2000-10-04	2007-02-15	Applied Research Systems	Use of mutants of cc chemokines for treatment of multiple sclerosis
GB0110430D0 (en) *	2001-04-27	2001-06-20	Medical Res Council	Protein variants and uses thereof
JP2003063980A (ja) *	2001-08-28	2003-03-05	Noevir Co Ltd	Ｒａｎｔｅｓ産生阻害剤
US6982170B1 (en) *	2001-12-17	2006-01-03	Maine Medical Center Research Institute	Compositions, methods and kits relating to thrombin degradation resistant fibroblast growth factor-1
JP2003306438A (ja) *	2002-02-18	2003-10-28	Shiseido Co Ltd	ケモカイン発現阻害剤
JP2003267887A (ja) *	2002-03-15	2003-09-25	Shiseido Co Ltd	ケモカイン発現抑制皮膚外用剤
IL164376A0 (en) *	2002-04-03	2005-12-18	Applied Research Systems	Ox4or binding agents, their preparation and pharmaceutical compositions containing them
AU2003240765A1 (en) *	2002-04-10	2003-10-20	Applied Research Systems Ars Holding N.V.	Novel antagonists of mcp proteins
AT412785B (de) *	2003-12-04	2005-07-25	Kungl Andreas J Dr	Gag-bindungsproteine

2003
- 2003-12-04 AT AT0195203A patent/AT412785B/de not_active IP Right Cessation
2004
- 2004-12-02 DK DK04801190.2T patent/DK1689775T3/da active
- 2004-12-02 ES ES06117339T patent/ES2330362T3/es active Active
- 2004-12-02 BR BRPI0416544-6A patent/BRPI0416544A/pt not_active IP Right Cessation
- 2004-12-02 PT PT06117339T patent/PT1752470E/pt unknown
- 2004-12-02 ES ES04801190T patent/ES2369139T3/es active Active
- 2004-12-02 SI SI200431257T patent/SI1752470T1/sl unknown
- 2004-12-02 PT PT04801190T patent/PT1689775E/pt unknown
- 2004-12-02 DK DK06117339T patent/DK1752470T3/da active
- 2004-12-02 KR KR1020127011106A patent/KR101278459B1/ko not_active IP Right Cessation
- 2004-12-02 EP EP10180974A patent/EP2270038A3/de not_active Withdrawn
- 2004-12-02 KR KR1020067013411A patent/KR101188785B1/ko not_active IP Right Cessation
- 2004-12-02 DE DE602004022595T patent/DE602004022595D1/de active Active
- 2004-12-02 NZ NZ547612A patent/NZ547612A/en not_active IP Right Cessation
- 2004-12-02 PL PL06117339T patent/PL1752470T3/pl unknown
- 2004-12-02 AT AT04801190T patent/ATE515269T1/de active
- 2004-12-02 EP EP06117339A patent/EP1752470B1/de not_active Not-in-force
- 2004-12-02 CA CA002546789A patent/CA2546789A1/en not_active Abandoned
- 2004-12-02 WO PCT/EP2004/013670 patent/WO2005054285A1/en active Application Filing
- 2004-12-02 EP EP04801190A patent/EP1689775B1/de active Active
- 2004-12-02 AU AU2004295104A patent/AU2004295104B2/en not_active Ceased
- 2004-12-02 EP EP10174625A patent/EP2363411A1/de not_active Withdrawn
- 2004-12-02 SI SI200431747T patent/SI1689775T1/sl unknown
- 2004-12-02 CN CN200480036160.6A patent/CN1890264B/zh not_active Expired - Fee Related
- 2004-12-02 EP EP10180909A patent/EP2311866A1/de not_active Withdrawn
- 2004-12-02 SG SG200809009-4A patent/SG149000A1/en unknown
- 2004-12-02 AT AT06117339T patent/ATE439376T1/de active
- 2004-12-02 JP JP2006541888A patent/JP4980721B2/ja not_active Expired - Fee Related
- 2004-12-02 PL PL04801190T patent/PL1689775T3/pl unknown
2006
- 2006-05-11 IL IL175565A patent/IL175565A0/en unknown
- 2006-06-05 US US11/422,169 patent/US7585937B2/en not_active Expired - Fee Related
2008
- 2008-06-02 US US12/131,311 patent/US7807413B2/en not_active Expired - Fee Related
2009
- 2009-05-07 US US12/437,121 patent/US20110144305A1/en not_active Abandoned
- 2009-10-08 CY CY20091101039T patent/CY1109480T1/el unknown
2010
- 2010-08-18 US US12/858,456 patent/US20100331237A1/en not_active Abandoned
2011
- 2011-09-16 CY CY20111100904T patent/CY1112330T1/el unknown
2012
- 2012-02-27 JP JP2012040123A patent/JP2012139226A/ja active Pending
- 2012-04-05 JP JP2012086483A patent/JP2012165747A/ja active Pending

Also Published As

Publication number	Publication date
DK1752470T3 (da)	2009-12-14
EP2270038A2 (de)	2011-01-05
US20110144305A1 (en)	2011-06-16
IL175565A0 (en)	2006-09-05
DK1689775T3 (da)	2011-09-26
JP2012165747A (ja)	2012-09-06
EP2270038A3 (de)	2011-02-23
EP1689775B1 (de)	2011-07-06
JP2012139226A (ja)	2012-07-26
EP2311866A1 (de)	2011-04-20
BRPI0416544A (pt)	2007-01-09
CY1109480T1 (el)	2014-08-13
AT412785B (de)	2005-07-25
AU2004295104B2 (en)	2010-07-22
AU2004295104A1 (en)	2005-06-16
US20090005541A1 (en)	2009-01-01
ATE439376T1 (de)	2009-08-15
CN1890264B (zh)	2014-01-22
ES2330362T3 (es)	2009-12-09
US20080112926A1 (en)	2008-05-15
WO2005054285A1 (en)	2005-06-16
PT1689775E (pt)	2011-10-13
KR101278459B1 (ko)	2013-07-01
JP4980721B2 (ja)	2012-07-18
KR20070001917A (ko)	2007-01-04
ES2369139T3 (es)	2011-11-25
ATA19522003A (de)	2004-12-15
CY1112330T1 (el)	2015-12-09
DE602004022595D1 (de)	2009-09-24
US7807413B2 (en)	2010-10-05
KR101188785B1 (ko)	2012-10-16
CA2546789A1 (en)	2005-06-16
PL1689775T3 (pl)	2011-12-30
KR20120063542A (ko)	2012-06-15
EP1689775A1 (de)	2006-08-16
SI1689775T1 (sl)	2011-11-30
CN1890264A (zh)	2007-01-03
PT1752470E (pt)	2009-10-15
SI1752470T1 (sl)	2009-12-31
US7585937B2 (en)	2009-09-08
US20100331237A1 (en)	2010-12-30
NZ547612A (en)	2009-07-31
JP2007536906A (ja)	2007-12-20
PL1752470T3 (pl)	2010-01-29
SG149000A1 (en)	2009-01-29
EP1752470B1 (de)	2009-08-12
EP1752470A1 (de)	2007-02-14
EP2363411A1 (de)	2011-09-07

Legal Events

Date

Code

Title

Description

2012-02-15

UEP

Publication of translation of european patent specification

Ref document number: 1689775

Country of ref document: EP

Publication	Publication Date	Title
NO2017058I1 (no)	2017-11-10	HPV 58 L1 protein
ATE515269T1 (de)	2011-07-15	Gag-bindende proteine
NO2017012I1 (no)	2017-04-05	HPV 45 L1 protein
DE602004018654D1 (de)	2009-02-05	Se
ATE363383T1 (de)	2007-06-15	Schlingenware
DE502004001683D1 (de)	2006-11-16	Kabelführung
AT502792A5 (de)	2007-05-15	Düsenanpressvorrichtung
DE112004000620D2 (de)	2005-12-22	Struktoguss
DE502004000672D1 (de)	2006-07-20	Pigmentpreparationen
DE502004001524D1 (de)	2006-11-02	Hydrolager
ATA662003A (de)	2005-11-15	Trink-mundstück
ATE446959T1 (de)	2009-11-15	Chromenonindole
DE502004001629D1 (de)	2006-11-16	Bremsenprüfstand
DE502004002978D1 (de)	2007-04-05	N-biarylamide
DE502004000518D1 (de)	2006-06-14	Mitgängergabelhubwagen
DE10355350A8 (de)	2006-11-09	Elektromodul
DE502004005162D1 (de)	2007-11-15	Leistungsregelvorricthung
ATE406350T1 (de)	2008-09-15	Prolinylarylacetamide
DE112004002227D2 (de)	2006-07-27	Nietverarbeitungsgerät
NO20053512D0 (no)	2005-07-18	IL-8-liknende proteiner
DE10329218B4 (de)	2007-05-16	Hotflue
DE112004001561D2 (de)	2006-06-01	Getriebene-Antreibseinheit
DE502004004175D1 (de)	2007-08-09	Verbrennungskraftmaschime
DE502004002771D1 (de)	2007-03-15	Umlenkhebel
DE502004002619D1 (de)	2007-02-22	Flaschenverschluss